ABSTRACT The FGF pathway regulates a variety of developmental processes in animals through activation and/or repression of numerous target genes. Here we have identified a Xenopus homolog of potassium channel tetramerization domain containing 15 (KCTD15) as an FGF-repressed gene. Kctd15 expression is first detected at the gastrula stage and gradually increases until the tadpole stage. Whole-mount in situ hybridization reveals that the spatial expression of kctd15 is tightly regulated during early embryogenesis. While kctd15 is uniformly expressed throughout the presumptive ectoderm at the early gastrula stage, its expression becomes restricted to the non-neural ectoderm and is excluded from the neural plate at the early neurula stage. At the mid-neurula stage, kctd15 shows a more restricted distribution pattern in regions that are located at the anterior, lateral or medial edge of the neural fold, including the preplacodal ectoderm, the craniofacial neural crest and the prospective roof plate. At the tailbud stage, kctd15 expression is mainly detected in neural crest-or placode-derived tissues that are located around the eye, including the mandibular arch, trigeminal ganglia and the olfactory placode. FGF represses kctd15 expression in ectodermal explants, and the inhibition of FGF receptor with a chemical compound dramatically expands the region expressing kctd15 in whole embryos. Dorsal depletion of kctd15 in Xenopus embryos leads to bent axes with reduced head structures, defective eyes and abnormal somites, while ventral depletion causes defects in ventral and caudal morphologies. These results suggest that kctd15 is an FGF-repressed ectodermal gene required for both dorsal and ventral development.
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Fibroblast growth factor (FGF) is a key secreted factor that controls cell proliferation, cell differentiation and various developmental processes in animals (Böttcher and Niehrs, 2005; Thisse and Thisse, 2005) . In early Xenopus development, FGF and its major downstream signaling pathway, the Ras/MAPK pathway, play an essential role in mesoderm formation and neural induction (De Robertis and Kuroda, 2004; Heasman, 2006) . The FGF/Ras/ MAPK pathway functions through transcriptional activation and/or repression of numerous but specific target genes, which include a wide variety of transcriptional factors, regulators of the intracellular signal transduction pathway and secreted factors (Chung et al., 2004; Böttcher and Niehrs, 2005; Thisse and Thisse, 2005; Branney et al., 2009) . In this study, we have identified a Xenopus homolog of potassium channel tetramerization domain containing 15 (KCTD15) as an FGF-repressed gene.
KCTD15 is a member of the KCTD family sharing a common N-terminal domain, the potassium channel tetramerisation domain (also known as the T1 domain) that is homologous to the cytoplasmic domain of voltage-gated potassium channels. This domain is a close relative of the BTB (Broad-Complex, Tramtrack and Bric a brac)/POZ (poxvirus and zinc finger) domain, which is a major protein-protein interaction motif found in viruses and throughout eukaryotes (Perez-Torrado et al., 2006) . Although the role of the KCTD family members remains largely unknown, several studies suggest that they are involved in various biological processes. For example, it has been shown that KCTD11 is deleted in human medulloblastoma and negatively regulates the Hedgehog signaling pathway by ubiquitin-mediated proteolysis (Di Marcotullio et al., 2004; Canettieri et al., 2010) . Also, KCTD8, 12 and 16 have been identified as auxiliary GABA B receptor subunits that determine the pharmacology and kinetics of the receptor response (Schwenk et al., 2010; Bartoi et al., 2010) .
KCTD15 genes are present in human and other vertebrates (also see Fig. 1 C,D) , and previous genome-wide association studies have shown that human KCTD15 is one of candidate genes that are associated with adult obesity risk (Thorleifsson et al., 2009; Willer et al., 2009) . Moreover, it has been recently shown that zebrafish homologs of KCTD15 inhibit neural crest formation by interfering with the Wnt/beta-catenin signaling pathway (Dutta and Dawid, 2010) . These findings thus raise the possibility that KCTD15 is a commonly used signaling molecule that regulates multiple biological phenomena in vertebrates. In this study, we describe the developmental expression and function of Xenopus kctd15, thereby providing more insights into the role of KCTD15 in vertebrates.
Results

Xenopus kctd15 is a novel FGF-repressed gene
Through a preliminary microarray experiment, in which the expression profile of Xenopus ectodermal explants treated with FGF was compared with that of untreated control explants (Kusakabe and 
Fig. 1. Evolutionary conservation of Xenopus kctd15, a novel FGFrepressed gene. (A) Xenopus
.. ***************************.*****.************** TKYPDSRISRLFNGTEPIVLDSLKQHYFIDRDGEIFRYILSFLRTSKLLLPEDFKEINLLYEEAKYYQLLPMVKELERWK 128 **************************************.**.***.*****.***...******.****.**..*****. 129:DSLKQHYFIDRDGEIFRYILSFLRTSKLLLPEDFKEINLLYEEAKYYQLLPMVKELERWKHVIRFPLNGYCRLNSVQVLE 208 ******************.**.***.*****.***...******.****.**..*****.*****************... (Fig. 1A) . Ras is an essential component of the FGF signaling pathway (Böttcher and Niehrs, 2005; Thisse and Thisse, 2005) . Overexpression of a constitutively active mutant of human Ras (hRasV12) led to a more significant decrease in the expression level of kctd15 than that observed in FGF-treated explants (Fig. 1A) . These results suggest that the FGF/Ras signaling pathway negatively regulates kctd15 expression in Xenopus embryos. Xenopus kctd15 protein consists of 255 amino acids and has the potassium channel tetramerization domain (Pfam accession number PF02214), a close relative of the BTB domain (Pfam accession number PF00651) (Fig. 1B) . The potassium channel tetramerization domain and the BTB domain constitute the BTB superfamily (superfamily cluster accession number cl02518) that is defined in the NCBI conserved domain database. Xenopus kctd15 protein shows 90-95% amino acid identity with its orthologs in other vertebrate species ranging from fish to human ( Fig. 1 C,D) . This high degree of sequence conservation suggests that KCTD15 plays a fundamental role in vertebrates.
Temporal and spatial expression of Xenopus kctd15
We next examined the temporal expression pattern of Xenopus kctd15 during early embryogenesis by real-time quantitative RT-PCR analysis. Maternal transcripts were not detected (Fig. 1E ). The expression was first detected at the early gastrula stage (stage 10.5) and gradually increased until the tadpole stage (stage 40) (Fig. 1E ). This result indicates that the expression level of kctd15 is regulated during embryogenesis. We then analyzed the spatial expression pattern of kctd15 by whole-mount in situ hybridization. At the early gastrula stage (stage 10.5), kctd15 transcripts were uniformly present throughout the presumptive ectoderm in the animal region, and no obvious expression was detected in the vegetal region ( Fig. 2 A-C) . At the early neurula stage (stage 14), kctd15 expression became restricted to the non-neural ectoderm and was excluded from the neural plate (Fig. 2 D-G) . At the mid-neurula stage (stage 16), kctd15 showed a more restricted distribution pattern in specific areas that are located at the anterior, lateral or medial edge of the neural fold ( Fig. 2 H-J) . The most prominent expression was found within the presumptive neural crest (nc) lying just lateral to the neural plate (Fig. 2J ). This region was roughly divided into two distinct subregions (Fig. 2J ). The anterior one may be a part of the putative craniofacial neural crest including the mandibular crest, and the posterior one may be a part of the putative trunk neural crest (Sadaghiani and Thiébaud, 1987) . Also, kctd15 expression was detected in the narrow crescent-shaped region surrounding the anterior neural plate, which corresponds to the preplacodal ectoderm (ppe) (Fig. 2H) , and the medial edge of the neural fold, which corresponds to the prospective roof plate (rf) (Fig. 2J) . At the late neurula stage (stage 18), kctd15 expression was detected in the neural crest, the roof plate and the olfactory placode (pOl) (Fig. 2 K-M) . At the tailbud stage (stage 25), kctd15 expression was mainly detected in neural crest-or placode-derived tissues that are located around the eye, including the olfactory placode, the mandibular arch (Md), the hyoid arch (Hy), trigeminal ganglia (tg) and the anterodorsal lateral line placode (pAD) (Fig. 2 N-P) . Also, the faint expression was detected in the putative pronephric duct (pd) (Fig. 2N ). To confirm that kctd15 is expressed in the neural crest, we performed whole mount double in situ hybridiza- (Amaya et al., 1991; Chung et al., 2004) .
was detected in the non-neural ectoderm and was excluded from the neural plate. Dorsal is upward in D and E. Anterior is upward in F and G. (H-J) At stage 16, kctd15 expression was detected in the preplacodal ectoderm (ppe), the neural crest (nc) and the roof plate (rf). Dorsal is upward in H and I. Anterior is upward in J. (K-M)
tion on stage 17 embryos, and compared the expression pattern of kctd15 with that of an early neural crest marker sox10. The region expressing kctd15 overlapped with anterior and posterior parts, but not the middle part, of the region expressing sox10 (Fig. 2Q) , indicating that kctd15 is expressed in specific areas of the neural crest. Our results thus reveal that kctd15 shows a temporally and spatially regulated expression pattern during early Xenopus development.
Xenopus kctd15 expression is suppressed by FGF signaling in vivo
In order to investigate whether FGF represses kctd15 expression directly or indirectly, animal cap explants were dissected from gastrula embryos, and incubated with FGF in the presence or absence of a protein synthesis inhibitor cycloheximide (CHX). The expression level of kctd15 was then analyzed by real-time quantitative RT-PCR analysis. In the absence of CHX, FGF led to a 34% reduction in the expression level of kctd15 (Fig. 3A , two left bars in the left graph), while in the presence of CHX, FGF led to only a 12% reduction (Fig. 3A , two right bars in the left graph). As a positive control, we also examined the expression level of xbra, an established direct target of FGF (Smith et al., 1991) . FGF-dependent increase in xbra expression is 2.6-fold in the absence of CHX, while it is 3.6-fold in the presence of CHX ( Fig  3A, the right graph) , confirming that xbra induction by FGF is direct. For unknown reasons, CHX treatment increased basal expression levels of kctd15 and xbra. These results imply that FGF represses kctd15 expression in an indirect manner that is predominantly dependent on de novo protein synthesis.
We next examined whether FGF represses kctd15 expression in vivo. Real-time quantitative RT-PCR analysis indicated that embryos overexpressing XFD, a dominant negative form of Xenopus FGF receptor 1 (Amaya et al., 1991) , exhibited an increase in the amount of kctd15 mRNA, compared with control embryos (Fig. 3B, left) . Moreover, treatment of embryos with a chemical inhibitor of FGF receptor, SU5402, led to a dose-dependent increase in the amount of kctd15 mRNA (Fig.  3B, right) . These results indicate that the FGF pathway controls the amount of kctd15 mRNA to an adequate level. Also, whole-mount in situ hybridization was performed to investigate whether the FGF pathway is responsible for the spatial controlled expression pattern of kctd15. SU5402 treatment from the blastula stage onwards dramatically expanded the region expressing kctd15 in embryos at the mid-neurula stage (stage 15) with dose dependency: kctd15 expression restricted to the anterior or anterolateral neural plate border in control embryos while it expanded to the anterior abdomen and the posterior neural plate border in SU5402-treated embryos (Fig. 3C) . These results thus strongly suggest that FGF signaling restricts kctd15 expression in vivo.
Xenopus kctd15 is essential for head and somite development
To examine the function of Xenopus kctd15 in early embryonic development by a loss-of-function approach, we designed an antisense morpholino oligonucleotide (MO) against kctd15. To check the ability of kctd15 MO to block translation from kctd15 mRNA, the combination of GFP mRNA plus control MO or kctd15 MO was co-injected with kctd15-myc mRNA, which consisted of the 5'UTR and the coding region of kctd15 with a myc tag at the C terminus. Immunoblot analysis revealed that kctd15 MO markedly reduced the protein abundance of kctd15-myc, but not that of GFP (Fig. 4A, two right lanes) . Thus, kctd15 MO is specific and efficient. Control MO or kctd15 MO was then injected into animal poles of dorsal blastomeres at the four-cell stage, and injected embryos were allowed to develop. At the late tailbud stage, embryos dorsally injected with kctd15 MO exhibited bent axes with reduced head structures, defective eyes and abnormal somites, whereas embryos injected with control MO were almost normal (Fig. 4 B,C) . We classified the phenotypes of MO-injected embryos into three groups according to the extent of defects in head morphologies (Fig. 4D) . Thirty-nine percent of kctd15 MO-injected embryos showed severe phenotypes comprising reduced head structures with no eyes, 61% of those showed milder phenotypes comprising reduced head structures with small eyes, and 0% of those had normal head structures (Fig. 4D) . Also, we classified the phenotypes of injected embryos into three groups according to the extent of defects in somite morphologies (Fig. 4E) . Thirty percent of kctd15 MO-injected embryos showed severe phenotypes comprising a decrease in both the dorsoventral length and the anteroposterior width of each somitic unit, 56% of those showed milder phenotypes with the normal dorsoventral length but the decreased anteroposterior width of each somitic unit, and only 14% of those had normal somites (Fig. 4E) . Next, to confirm the specificity of kctd15 MO, we performed rescue experiments with an N-terminally myc-tagged kctd15 (myc-kctd15), which contains the full-length coding sequence but not the 5'UTR. Kctd15 MO did not suppress the protein abundance of myc-kctd15 (Fig. 4A,  lanes 2 and 3) , indicating that myc-kctd15 is a kctd15 MO-resistant construct. We then examined whether co-injection of myc-kctd15 mRNA rescues the phenotype induced by kctd15 MO (Fig. 4 B-E) . When coinjected, the percentage of embryos with severe defects in head morphologies was decreased to 15%, while the percentage of those with normal heads was increased to 22%. Also, defects in somite morphologies were partially rescued by coinjection: the percentage of embryos with severe defects was decreased to 13%, while the percentage of those with normal somites was increased to 35%. The observed phenotypes in kctd15 morphants are thus largely due to the depletion of kctd15 protein.
We next performed real-time quantitative RT-PCR analysis to elucidate a molecular basis for these phenotypes. Because kctd15 is expressed in the neural plate border including the neural crest (Fig. 2) , we first examined the expression levels of the neural plate border specifier, pax3, and neural crest markers, foxd3 and sox10. At the mid-neurula stage (stage 15), dorsal injection of kctd15 MO led to a slight or moderate increase in expression of foxd3, sox10 and pax3 (Fig. 4F) . Moreover, the expression levels of neural markers, sox2 and ncam, were also increased by kctd15 MO (Fig.  4G) . These results suggest that dorsal depletion of kctd15 leads to hyperplasia of neural crest and neural tissues. Also, we analyzed the expression level of xbra, which is required for somite formation (Conlon et al., 1996) . Xbra expression at the late neurula stage (stage 19) was reduced to about 60% by kctd15 MO (Fig. 5H) , suggesting the possibility that somitic defects caused by kctd15 depletion are partly due to downregulation of xbra. By contrast, dorsal depletion of kctd15 did not significantly affect the expression level of the bHLH transcription factor mesogenin1/mespo, a major Wnt/ beta-catenin target gene critical for somite segmentation (Wang et al., 2007 , Chalamalasetty et al., 2011 , at stage 19 (Fig. 4I) . Thus, dysregulation of Wnt/beta-catenin signaling during somitogenesis might not be primarily responsible for somatic defects caused by kctd15 depletion.
Xenopus Kctd15 is essential for ventral and caudal development
Next, kctd15 MO was injected into animal poles of ventral blastomeres at the four-cell stage. At the late tailbud stage, injected embryos exhibited defects in ventral and caudal morphologies (Fig.  5A ). Thirty-four percent of kctd15 MO-injected embryos showed severe phenotypes with poorly extended tails and reduced ventral tissues, 36% of those showed milder phenotypes with poorly extended tails but the relatively normal ventral morphology, and 30% of those showed no phenotypes (Fig. 5B) . Coinjection of myc-kctd15 mRNA rescued the phenotype induced by kctd15 MO: eleven percent of coinjected embryos showed severe phenotypes, 17% of those showed mild phenotypes, and 71% of those had no phenotypes (Fig. 5B) . The observed phenotypes in kctd15 morphants are thus largely due to ventral depletion of kctd15.
The expression levels of marker genes were also examined by real-time quantitative RT-PCR analysis. Ventral injection of kctd15 (Fig. 5C) . Also, at the late neurula stage (stage 19), the expression level of xbra, which is important for posterior mesoderm formation in addition to somite formation (Conlon et al., 1996) , was decreased by ventral depletion of kctd15 (Fig. 5D ). We also focused on caudal type homeobox transcription factors, cdx2 and cdx4, which are important for posterior axial elongation (Mallo et al., 2010) . The expression level of cdx4 at the early tailbud stage (stage 24), but not that of cdx2, was increased by ventral depletion of kctd15 (Fig. 5E ). These changes in gene expression may potentially contribute to defects in ventral or caudal morphologies observed in embryos ventrally injected with kctd15 MO. 
Dorsal activation of FGF signaling partially phenocopies dorsal depletion of Xenopus kctd15
Finally, to test whether the FGF pathway is related to phenotypes observed in kctd15 morphants, wild-type Xenopus FGF receptor 1 (fgfr1 WT) mRNA was injected into animal poles of dorsal or ventral blastomeres at the four-cell stage. At the late tailbud stage, embryos dorsally injected with 100 or 200 pg of fgfr1 WT mRNA showed similar defects in head and somite development to those observed in embryos dorsally injected with kctd15 MO (Fig. 6 A-C) . Embryos dorsally injected with 400 pg of fgfr1 WT mRNA showed much severer defects including spina bifida (Fig. 6 A-C) , which was not observed in kctd15 morphants (Fig. 4B ). These data suggest that moderate activation of FGF signaling in the dorsal halves of embryos partially phenocopies dorsal depletion of kctd15. Meanwhile, embryos ventrally injected with 100 pg or 200 pg of fgfr1 WT mRNA showed normal tail extension with or without ectopic posterior protrusions, while those ventrally injected with 400 pg of fgfr1 WT mRNA showed truncated anteroposterior axes or ectopic posterior protrusions (Fig.  6D ). These phenotypes were not observed in embryos ventrally injected with kctd15 MO (Fig. 5A) , suggesting that ventral activation of FGF signaling does not phenocopy ventral depletion of kctd15. Taken together, downregulation of kctd15 expression may partly mediate the action of FGF signaling in a context-dependent manner.
Discussion
In this study, we have identified Xenopus kctd15 as an FGF-repressed gene. Kctd15 is not maternally expressed, and its zygotic transcription begins during gastrulation. While kctd15 is uniformly expressed throughout the presumptive ectoderm at the early gastrula stage, its expression becomes restricted to the non-neural ectoderm at the At mid-to late neurula stages, kctd15 shows a more restricted distribution pattern in the prospective neural crest, the preplacodal ectoderm and the prospective roof plate. At the tailbud stage, kctd15 expression is mainly detected in neural crest-or placode-derived tissues surrounding the eye. Dorsal depletion of kctd15 in Xenopus embryos leads to bent axes with reduced head structures, defective eyes and abnormal somites, while ventral depletion causes defects in ventral and caudal morphologies. These results thus suggest that Xenopus kctd15 plays a crucial role in early embryonic development. The recent study showed the spatial expression pattern of two zebrafish KCTD15 orthologs, kctd15a and kctd15b (Dutta and Da-wid, 2010) . At the 1-somite stage, both genes are mainly expressed in the neural plate border. At later stages, zebrafish kctd15a is mainly expressed in pronephric ducts, cranial placode precursors and the brain, while zebrafish kctd15b is mainly expressed in the olfactory placode, the cranial neural crest, pharyngeal arches, fin buds and the optic tectum. Thus, the expression pattern of zebrafish kctd15a/b is not identical to, but overlaps with, that of Xenopus kctd15. It has also been shown that zebrafish embryos injected with MOs against kctd15a and kctd15b exhibit small heads and abnormal somites (Dutta and Dawid, 2010) . These phenotypes are very similar to those observed in Xenopus embryos dorsally injected with kctd15 MO (Fig. 4) . It can be therefore assumed that the function of KCTD15 in dorsal development is conserved in both zebrafish and Xenopus.
Our results also showed that ventral depletion of Xenopus kctd15 causes defects in ventral and caudal morphologies, including poorly extended tails and reduced ventral tissues (Fig. 5) . Although the previous study in zebrafish did not mention ventral and caudal morphologies in embryos depleted of both Kctd15a and Kctd15b, poorly extended tails seem to be observed in morphants (see Fig.  1J -M in Dutta and Dawid, 2010) . Therefore, the function of KCTD15 in caudal development may be conserved in both zebrafish and Xenopus. Further analyses in other vertebrates are necessary to demonstrate an evolutionary conservation of KCTD15 function in development.
What mechanisms could be responsible for the observed phenotypes in Xenopus embryos depleted of kctd15? Our quantitative RT-PCR results showed that dorsal depletion of kctd15 leads to an increase in expression of neural crest and neural markers (Fig. 4) . Because the previous study in zebrafish has shown that knockdown of both kctd15a and kctd15b leads to the expansion of the neural crest (Dutta and Dawid, 2010) , malformation of the cranial neural crest would be a primary cause of defects in head morphologies induced by dorsal injection of kctd15 MO. Hyperplasia of neural tissues could be an additional potential cause. Also, dorsal depletion of kctd15 leads to a decrease in expression of xbra (Fig. 4) . Xbra and its homologs (zebrafish no tail and mouse Brachyury) are implicated in somite formation (Wardle and Papaioannou, 2008) . Thus, downregulation of xbra expression may be relevant to defects in somite morphologies.
Our quantitative RT-PCR results also reveal that ventral depletion of Xenopus kctd15 caused an increase in cdx4 expression and a decrease in xbra expression (Fig. 5) . Xenopus embryos ventrally injected with cdx4 mRNA had poorly extended tails, although the authors did not mention it (see Fig. 7H in Pownall et al., 1996) . Moreover, xbra homologs are required for tail formation in vertebrates including zebrafish, Xenopus and mouse (Wardle and Papaioannou, 2008) . Thus, changes in cdx4 and xbra expression may be primarily responsible for the defects in caudal morphologies observed in Xenopus embryos ventrally injected with kctd15 MO. Because ventral depletion of kctd15 also leads to a slight increase in expression of neural crest markers (Fig. 5) , excess neural crest-derived tissues in the ventral region could be an additional potential cause. Because Xenopus kctd15 shows a characteristic expression pattern in various tissues (Fig. 2) , other multiple factors in addition to those described above also might contribute to the phenotypes of kctd15 knockdown embryos.
The interplay between the FGF and Wnt signaling pathways regulates a variety of developmental processes (Dailey et al., 2005) .
In the previous study, KCTD15 has been shown to antagonize the canonical Wnt pathway (Dutta and Dawid, 2010 ). Because we have here identified Xenopus kctd15 as an FGF/Ras-repressed gene, it can be speculated that the FGF/Ras pathway indirectly promotes the Wnt pathway by repressing kctd15 expression. Our results of whole-mount in situ hybridization definitely indicate that FGF-mediated transcriptional repression of kctd15 contributes to the region-specific expression of kctd15, which might result in the region-specific activation or repression of Wnt signaling that is responsible for proper embryonic development. We recently reported that another Ras-repressed gene, eig121l, is specifically expressed in the ventral ectoderm and acts as a positive regulator of the BMP pathway (Araki et al., 2007; Araki et al., 2011) . Thus, FGF/Ras-induced transcriptional repression of signaling molecules may represent a mechanism mediating the crosstalk among multiple signaling pathways.
Materials and Methods
Molecular cloning and plasmid construction
The full-length of Xenopus kctd15 was already deposited in GenBank (GenBank accession number BC077862). We designed primers on the basis of the deposited sequences, and performed RT-PCR with complementary DNAs (cDNAs) derived from embryos at stage 12. The amplified entire coding sequence was cloned into the pBluescript vector for RNA probe synthesis.
Embryo manipulations
Xenopus laevis embryos were obtained by in vitro fertilization and cultured in 0.1 x MBS (1.0 mM HEPES, pH 7.4, 8.8 mM NaCl, 0.1 mM KCl, 0.24 mM NaHCO 3 , 0.082 mM MgSO 4 , 0.03 mM Ca(NO 3 ) 2 and 0.041 mM CaCl 2 ). Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967) . Injection of embryos was performed in 4% Ficoll in 0.1 x MBS. For animal cap assay, human RasV12 mRNA was injected into animal poles of four-cell stage embryos. Ectodermal explants were dissected at stage 8 (Fig. 1A) or 10.25 (Fig. 3A) and cultured in 1 x Steinberg's solution (10 mM Hepes, pH 7.4, 60 mM NaCl, 0.67 mM KCl, 0.83 mM MgSO 4 and 0.34 mM Ca(NO 3 ) 2 ) containing 1 mg/ml BSA (Sigma). The explants were harvested at indicated stages for RT-PCR. For the whole embryo phenotypes, antisense morpholino oligonucleotides (MOs) were injected into animal poles of two dorsal or ventral blastomeres at the four-cell stage (40 ng of each MO per blastomere). The injected embryos were cultured in 4% Ficoll in 0.1 x MBS until stage 9, and then transferred to 0.1 x MBS.
Quantitative reverse transcription-PCR
Total RNA was extracted from whole embryos or animal caps using TRIzol reagent (Invitrogen). cDNA was synthesized using M-MLV reverse transcriptase (Invitrogen). For real-time quantitative RT-PCR analysis, we used 7300 real-time PCR System (Applied Biosystems) with SYBR Green PCR Master Mix (QIAGEN). The primers for ef1a have been previously described (Gotoh et al., 1995) . The other sequences of primer pairs used were as follows: odc forward 5'-TGCAAGTTGGAGACTGGATG reverse 5'-CATCAGTTGCCAGTGTGGTC kctd15 forward 1 (f1) 5'-ATTGCTCTAAGCGGAGAAAAGG forward 2 (f2) 5'-TGGCTGCCCAAGGAATACCTCTTCC reverse 1 (r1) 5'-ACTAAACTGCGAGGAGTCAACG reverse 2 (r2) 5'-ACTTTGTCAGGGTGGCCAGACTGC foxd3 forward 5'-CCTGTCAGGCAGCGGCAGTG reverse 5'-CTTGTCCAGCGCCTCGTCCC sox10 forward 5'-AGAGGAGGCTGAGAGGCTGCG reverse 5'-ACCCTCGGCTTCAGAGGACCC pax3 forward 5'-AGCAGCGCAGGAGCAGAACC
